Publications
5808 Results
- Journal / Conference
- Seminars in Oncology, Oct;42(5):740-747
- Year
- 2015
- Research Committee(s)
- Cancer Care Delivery and Multiple sites
- PMID
- PMID26433555
- PMC
- PMC4604069
Enhancing adolescent and young adult oncology research within the National Clinical Trials Network: rationale, progress, and strategies
- Journal / Conference
- San Antonio Breast Cancer Symposium (December 8-12, 2015, San Antonio, TX), poster, abst.# P3-07-64;
- Year
- 2015
- Research Committee(s)
- Breast
- Study Number(s)
- S0226
Association between gene variants in SULT1A1 and UGT1A4 and disease outcomes in patients enrolled in SWOG S0226 and treated with anastrozole alone or in combination with fulvestrant for metastatic breast cancer
- Journal / Conference
- Nature, May 14;521(7551):S6-8
- Year
- 2015
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID25970457
- PMC
- not applicable (published interview with Dr. Zell)
- Study Number(s)
- S0820
Prevention: Tending the gut [Outlook/Opinion; published interview with Dr. J. Zell]
- Journal / Conference
- Journal of Clinical Oncology 33 (suppl; abstr 7034); ASCO Annual Meeting (5/29-6/2/15, Chicago, IL), poster session;
- Year
- 2015
- Research Committee(s)
- Lymphoma and Myeloma
The impact of HBO on early ALC recovery following high-dose therapy and autologous transplantation [SWOG/Hope Foundation Pilot Study]
- Journal / Conference
- Bulletin of the American College of Surgeons, Aug;100(8):70-71
- Year
- 2015
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID26419059
- Study Number(s)
- S0820
PACES trial: Evaluating the effectiveness of eflornithine and sulindac in preventing colon adenomas [Review]
- Journal / Conference
- San Antonio Breast Cancer Symposium 2015 (Dec 8-12, 2015, San Antonio, TX), oral, abst.# P5-07-01;
- Year
- 2015
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8814
Molecular predictors of outcome on adjuvant CAF plus tamoxifen (T) vs T in postmenopausal patients (pts) with ER+, node+ breast cancer – transcriptome expression analysis of the phase III trial SWOG-8814
- Journal / Conference
- San Antonio Breast Cancer Symposium 2015 (Dec 8-12, 2015, San Antonio, TX), poster, abst.# P5-07-01;
- Year
- 2015
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8814
Successful whole transcriptome analysis of 25-year-old samples from the phase III trial SWOG-8814 by next generation sequencing (NGS): Standardized analytical methods for exploratory and validation studies
- Journal / Conference
- San Antonio Breast Cancer Symposium 2015 (Dec 8-12, 2015, San Antonio, TX), abst. S6-05;
- Year
- 2015
- Research Committee(s)
- Breast
Patient-reported outcome (PRO) results, NRG Oncology/NSABP B-35: A clinical trial of anastrozole (A) vs tamoxifen (tam) in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy
- Journal / Conference
- San Antonio Breast Cancer Symposium 2015 (Dec 8-12, 2015, San Antonio, TX), TIPs poster, abst.# OT1-03-11;
- Year
- 2015
- Research Committee(s)
- Breast
- Study Number(s)
- S1207
Phase III randomized, placebo-controlled clinical trial evaluating the use of adjuvant endocrine therapy +/- one year of everolimus in patients with high-risk, hormone receptor- (HR) positive and HER2-negative breast cancer: SWOG/NRG/Alliance S1207 (NCT01674140)
- Journal / Conference
- Journal of Clinical Oncology, Dec 1;33(34):4066-4076
- Year
- 2015
- Research Committee(s)
- Melanoma
- PMID
- PMID26351350
- PMC
- PMC4669592
- Study Number(s)
- E4697